151 related articles for article (PubMed ID: 33933504)
1. Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative.
Paudel R; Ferrante S; Qi J; Dunn RL; Berry DL; Semerjian A; Brede CM; George AK; Lane BR; Ginsburg KB; Montie JE; Lane GI;
Urology; 2021 Sep; 155():55-61. PubMed ID: 33933504
[TBL] [Abstract][Full Text] [Related]
2. Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer.
Bosco JL; Halpenny B; Berry DL
Health Qual Life Outcomes; 2012 Sep; 10():123. PubMed ID: 23021156
[TBL] [Abstract][Full Text] [Related]
3. The added influence of genomics and post-MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillance.
Wang M; Qi J; George AK; Semerjian A; Linsell SM; Montie JE; Cher ML; Ginsburg KB;
Prostate; 2022 Jun; 82(10):1068-1074. PubMed ID: 35468226
[TBL] [Abstract][Full Text] [Related]
4. Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer.
Ginsburg KB; Arcot R; Qi J; Linsell SM; Kaye DR; George AK; Cher ML;
J Urol; 2019 May; 201(5):923-928. PubMed ID: 30694939
[TBL] [Abstract][Full Text] [Related]
5. Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer.
Kaye DR; Qi J; Morgan TM; Linsell S; Lane BR; Montie JE; Cher ML; Miller DC;
Urology; 2018 Aug; 118():127-133. PubMed ID: 29792972
[TBL] [Abstract][Full Text] [Related]
6. Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.
Pozzar RA; Xiong N; Hong F; Filson CP; Chang P; Halpenny B; Berry DL
BMC Med Inform Decis Mak; 2022 Aug; 22(1):223. PubMed ID: 36002847
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer.
Liu J; Womble PR; Merdan S; Miller DC; Montie JE; Denton BT;
Urology; 2015 Nov; 86(5):901-5. PubMed ID: 26358397
[TBL] [Abstract][Full Text] [Related]
8. The Impact of a Statewide Active Surveillance Initiative: A Roadmap for Increasing Active Surveillance Utilization Nationwide.
Vince RA; Sun Y; Mahal B; Ginsburg K; George A; Cher M; Lane B; Sarle R; Morgan TM; Spratt DE
Eur Urol; 2023 Apr; 83(4):307-310. PubMed ID: 35688664
[TBL] [Abstract][Full Text] [Related]
9. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
[TBL] [Abstract][Full Text] [Related]
10. Early prostate cancer--which treatment do men prefer and why?
Anandadas CN; Clarke NW; Davidson SE; O'Reilly PH; Logue JP; Gilmore L; Swindell R; Brough RJ; Wemyss-Holden GD; Lau MW; Javle PM; Ramani VA; Wylie JP; Collins GN; Brown S; Cowan RA;
BJU Int; 2011 Jun; 107(11):1762-8. PubMed ID: 21083643
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Use of Prostate Biopsy Among Men with Limited Life Expectancy in a Statewide Quality Improvement Collaborative.
Abdollah F; Ye Z; Miller DC; Linsell SM; Montie JE; Peabody JO; Ghani KR;
Eur Urol; 2016 Nov; 70(5):854-861. PubMed ID: 27113032
[TBL] [Abstract][Full Text] [Related]
12. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trial.
Berry DL; Halpenny B; Hong F; Wolpin S; Lober WB; Russell KJ; Ellis WJ; Govindarajulu U; Bosco J; Davison BJ; Bennett G; Terris MK; Barsevick A; Lin DW; Yang CC; Swanson G
Urol Oncol; 2013 Oct; 31(7):1012-21. PubMed ID: 22153756
[TBL] [Abstract][Full Text] [Related]
13. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
15. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care.
Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME
J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032
[TBL] [Abstract][Full Text] [Related]
16. Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences.
Knight SJ; Latini DM
Cancer J; 2009; 15(1):41-4. PubMed ID: 19197172
[TBL] [Abstract][Full Text] [Related]
17. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
18. Treatment decision-making by men with localized prostate cancer: the influence of personal factors.
Berry DL; Ellis WJ; Woods NF; Schwien C; Mullen KH; Yang C
Urol Oncol; 2003; 21(2):93-100. PubMed ID: 12856636
[TBL] [Abstract][Full Text] [Related]
19. Repeat Prostate Biopsy Practice Patterns in a Statewide Quality Improvement Collaborative.
Burks FN; Hu JC; Telang D; Liu A; Hawken S; Montgomery Z; Linsell S; Montie JE; Miller DC; Ghani KR;
J Urol; 2017 Aug; 198(2):322-328. PubMed ID: 28257783
[TBL] [Abstract][Full Text] [Related]
20. askMUSIC: Leveraging a Clinical Registry to Develop a New Machine Learning Model to Inform Patients of Prostate Cancer Treatments Chosen by Similar Men.
Auffenberg GB; Ghani KR; Ramani S; Usoro E; Denton B; Rogers C; Stockton B; Miller DC; Singh K;
Eur Urol; 2019 Jun; 75(6):901-907. PubMed ID: 30318331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
